RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260536

FDA DEVICE FACTS

Prostalac Hip System, SmartSet V+G Dual Antibiotic Bone Cement

Depuy Ireland UC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 15, 2026PRODUCT CODEKWL

Indications for use

The PROSTALAC Hip System is indicated for use as a short-term total hip replacement (THR) in patients who need a two-stage procedure to treat a confirmed infection of their THR and where vancomycin combined with either tobramycin OR gentamicin are the most appropriate antibiotics for treatment of the infection based on the susceptibility pattern of the infecting microorganism(s). SmartSet V+G Dual Antibiotic Bone Cement is intended for use with the DePuy Prostalac Hip System. The SmartSet V+G Dual Antibiotic Bone Cement is indicated for the formation and fixation of the DePuy Prostalac Hip System to the host bone. Prescription Use. Age group: Adults (22 years old and greater).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026